Prolyl cis-trans isomerization as a molecular timer. 2007

Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 1030, Boston, Massachusetts 02215, USA. klu@bidmc.harvard.edu

Proline is unique in the realm of amino acids in its ability to adopt completely distinct cis and trans conformations, which allows it to act as a backbone switch that is controlled by prolyl cis-trans isomerization. This intrinsically slow interconversion can be catalyzed by the evolutionarily conserved group of peptidyl prolyl cis-trans isomerase enzymes. These enzymes include cyclophilins and FK506-binding proteins, which are well known for their isomerization-independent role as cellular targets for immunosuppressive drugs. The significance of enzyme-catalyzed prolyl cis-trans isomerization as an important regulatory mechanism in human physiology and pathology was not recognized until the discovery of the phosphorylation-specific prolyl isomerase Pin1. Recent studies indicate that both phosphorylation-dependent and phosphorylation-independent prolyl cis-trans isomerization can act as a novel molecular timer to help control the amplitude and duration of a cellular process, and prolyl cis-trans isomerization might be a new target for therapeutic interventions.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
February 2007, Molecular cell,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
July 2005, Nature structural & molecular biology,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
January 1993, Advances in protein chemistry,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
May 2007, Journal of the American Chemical Society,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
June 2002, Journal of the American Chemical Society,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
January 2004, The journal of peptide research : official journal of the American Peptide Society,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
August 2021, The journal of physical chemistry. B,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
August 2012, The journal of physical chemistry. B,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
June 1981, Biophysical journal,
Kun Ping Lu, and Greg Finn, and Tae Ho Lee, and Linda K Nicholson
January 1995, Journal of molecular biology,
Copied contents to your clipboard!